The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEvraz Regulatory News (EVR)

  • This share is currently suspended. It was suspended at a price of 82.52

Share Price Information for Evraz (EVR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 82.52
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 82.52
EVR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EVRAZ plc announces results of the Consent Solicitation for its outstanding U.S.$750,000,000 5.375 per cent. notes due 2023

8 Dec 2022 09:17

EVRAZ plc (EVR)


EVRAZ plc announces results of the Consent Solicitation for its outstanding U.S.$750,000,000 5.375 per cent. notes due 2023

08-Dec-2022 / 11:17 MSK

Dissemination of a Regulatory Announcement that contains inside information in accordance with the Market Abuse Regulation (MAR), transmitted by EQS Group.

The issuer is solely responsible for the content of this announcement.


NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN, ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT OR THE CONSENT SOLICITATION MEMORANDUM.

EVRAZ plc announces results of the Consent Solicitation for its outstanding U.S.$750,000,000 5.375 per cent. notes due 2023

London, 8 December 2022 – on 15 November 2022, EVRAZ plc (the “Issuer”) announced a consent solicitation in relation to the outstanding U.S.$750,000,000 5.375 per cent. notes due 2023 issued by the Issuer (Regulation S Notes: Common Code 153391572 / ISIN XS1533915721; Rule 144A Notes: Common Code 111731110 / ISIN US30050AAG85 / CUSIP 30050AAG8) (the “Notes”) on the terms and subject to the conditions set forth in the consent solicitation memorandum dated 15 November 2022 (the “Consent Solicitation Memorandum”). Capitalised terms used, but not defined herein, shall have the meanings given to them in the Consent Solicitation Memorandum.

The Appointment Extraordinary Resolution and the Amendment Extraordinary Resolution were each passed at the Meeting of Noteholders held on 7 December 2022. Each of the Appointment and the Amendments will become effective upon execution of (i) the Deed of Appointment and (ii) the Supplemental Trust Deed, which will be separately notified to investors by the Issuer.

The Issuer extends its gratitude for the support and cooperation demonstrated by investors, which has been reflected in the successful results of the Consent Solicitation.

 

Questions and requests for assistance in connection with the Consent Solicitation should be directed to the Information and Tabulation Agent:

Limited liability company “Legal Capital Investor Services”

Address:  10 Krivokolenny lane, bldg. 6, Moscow 101000, Russia

Email:   evraz@lcpis.ru

Phone:   +7 495 122 05 17

Website:  www.lcpis.ru

 

###

For further information:

 

Investor Relations

+7 495 232 1370

ir@evraz.com

 



ISIN: GB00B71N6K86, XS1533915721, XS1843443273,
Category Code: MSCH
TIDM: EVR
LEI Code: 5493005B7DAN39RXLK23
OAM Categories: 2.2. Inside information
Sequence No.: 207086
EQS News ID: 1507855

 
End of Announcement EQS News Service


fncls.ssp?fn=show_t_gif&application_id=1507855&application_name=news&site_id=london_south_east
Date   Source Headline
29th Apr 20201:16 pmRNSTransfer of shares out of treasury, Voting rights
27th Apr 20206:39 pmRNSEVRAZ PUBLISHES ITS SUSTAINABILITY REPORT FOR 2019
27th Apr 202010:47 amRNSPublication of share rights summary at NSM
24th Apr 20203:00 pmRNSNOTICE OF Q1 2020 TRADING UPDATE CONFERENCE CALL
16th Apr 20202:00 pmRNSUpdate on COVID-19
20th Mar 202011:00 amRNSEVRAZ signed US$750m syndicated credit facility
10th Mar 20206:00 pmRNSDividend - determination of currency amounts
27th Feb 20207:00 amRNSAnnual Financial Report
21st Feb 202010:34 amRNSNOTICE OF 2019 RESULTS AND CONFERENCE CALL DETAILS
30th Jan 20209:03 amRNSEVRAZ Q4 2019 TRADING UPDATE - CORRECTION
30th Jan 20207:00 amRNSEVRAZ Q4 2019 TRADING UPDATE
31st Dec 201910:00 amRNSAmendment of transshipment agreement
13th Dec 20191:00 pmRNSChange of Director's responsibilities
2nd Dec 20196:00 pmRNSChange of director's details
1st Nov 20197:00 amRNSEVRAZ Q3 2019 TRADING UPDATE
31st Oct 20193:15 pmRNSDisclosure on Tailings Storage Facilities
28th Oct 20199:54 amRNSNOTICE OF Q3 2019 TRADING UPDATE CONFERENCE CALL
18th Oct 20196:00 pmRNSACQUISITION - PILOT PLANT FOR TAILINGS PROCESSING
18th Oct 20197:00 amRNSEVRAZ holds Capital markets day
9th Sep 20193:00 pmRNSDirector/PDMR Shareholding
21st Aug 20194:00 pmRNSDividend - determination of currency amounts
16th Aug 20194:00 pmRNSAmendment of transshipment agreement
8th Aug 20197:00 amRNSHalf-year Report
2nd Aug 20198:19 amRNSNOTICE OF H1 2019 RESULTS, CONFERENCE CALL DETAILS
1st Aug 20196:01 pmRNSChange of registered office address
31st Jul 20191:17 pmRNSEVRAZ Q2 2019 TRADING UPDATE - CORRECTION
31st Jul 20197:00 amRNSEVRAZ Q2 2019 TRADING UPDATE
25th Jul 20194:31 pmRNSEVRAZ Priced 20 Billion Rouble Bond Issue
25th Jun 20198:42 amRNSModern Slavery Transparency Statement for 2018
20th Jun 20196:00 pmRNSHolding(s) in Company
20th Jun 20197:02 amRNSDirector/PDMR Shareholding
20th Jun 20197:00 amRNSCompletion of sale of existing shares of EVRAZ
19th Jun 20194:58 pmRNSIntended sale of existing ordinary shares of EVRAZ
18th Jun 20191:33 pmRNSResult of AGM
18th Jun 20198:40 amRNSReport on payments to governments for 2018
6th Jun 201910:00 amRNSChange of director's details
23rd May 20193:37 pmRNSEarly Redemption Notice of 6.50 Notes due 2020
14th May 20196:27 pmRNSDirector/PDMR Shareholding
3rd May 20196:02 pmRNSHolding(s) in Company
3rd May 20196:00 pmRNSHolding(s) in Company
3rd May 20195:05 pmRNSNotice of 2019 AGM
30th Apr 20193:54 pmRNSTransfer of shares out of treasury, Voting rights
29th Apr 201910:24 amRNSEVRAZ PUBLISHES ITS FIRST SUSTAINABILITY REPORT
29th Apr 20197:00 amRNSEVRAZ Q1 2019 TRADING UPDATE
26th Apr 20191:31 pmRNSEarly Redemption Notice
25th Apr 20196:29 pmRNSACQUISITION OF 100% IN LLC ZAPADNYE VOROTA
25th Apr 20199:00 amRNSChange of director's details
11th Apr 20198:37 amRNSNOTICE OF Q1 2019 TRADING UPDATE CONFERENCE CALL
2nd Apr 201912:36 pmRNSDirector/PDMR Shareholding
29th Mar 20191:24 pmRNSDirector/PDMR Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.